INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
71.14 USD   +2.74%
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/21Inari Medical's Shares Rise After Piper Sandler Initiates Coverage
MT
06/21Piper Sandler Starts Inari Medical at Overweight With $100 Price Target
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société INARI MEDICAL, INC.
06/07OKAMI MEDICAL ANNOUNCES FDA 510(k) CLEARANCE OF THE LOBO-7 and LOBO-9 VASCULAR OCCLUDER..
PR
05/27INARI MEDICAL, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/13Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
AQ
05/04INARI MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
05/04Inari Medical Reports First Quarter 2022 Financial Results
AQ
05/03INARI MEDICAL : Profile May 2022
PU
04/28Inari Medical to Present at the Bank of America 2022 Healthcare Conference
AQ
04/20Inari Medical to Announce First Quarter 2022 Financial Results
AQ
03/21Inari Medical Announces Closing of Underwriters' Over-Allotment Option in Connection wi..
AQ
03/15INARI MEDICAL, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/10Inari Medical Announces Pricing of Offering of Common Stock
AQ
03/10Inari Medical Announces Proposed Offering of Common Stock
AQ
03/01INARI MEDICAL : Appoints Robert Warner to Board of Directors - Form 8-K
PU
03/01INARI MEDICAL, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure,..
AQ
03/01Inari Medical Appoints Robert Warner to Board of Directors
AQ
02/23INARI MEDICAL : Profile February 2022
PU
02/23INARI MEDICAL : Presentation February 2022
PU
02/23INARI MEDICAL : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K
PU
02/23INARI MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
02/23Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results
AQ
02/15Inari Medical Announces First Patient Enrolled in the PEERLESS Trial, a Randomized Cont..
AQ
02/10Inari Medical to Announce Fourth Quarter and Full-Year 2021 Financial Results
AQ
02/01Inari Medical to Present at Upcoming Investor Conferences
AQ
01/10INARI MEDICAL : Reports Preliminary Fourth Quarter 2021 Revenue - Form 8-K
PU
01/10Inari Medical Reports Preliminary Fourth Quarter 2021 Revenue
AQ
2021Inari Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
2021INARI MEDICAL : Presentation November 2021
PU
2021INARI MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
2021Inari Medical Reports Third Quarter 2021 Financial Results - Form 8-K
PU
2021Inari Medical Reports Third Quarter 2021 Financial Results
GL
2021Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of L..
AQ
2021Inari Medical to Announce Third Quarter 2021 Financial Results
AQ
2021INARI MEDICAL : Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the ..
AQ
2021INARI MEDICAL : Appoints Dana G. Mead, Jr. to Board of Directors (Form 8-K)
PU
2021INARI MEDICAL, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure,..
AQ
2021INARI MEDICAL : Appoints Dana G. Mead, Jr. to Board of Directors
AQ
2021INARI MEDICAL : Appoints Pulmonologist Dr. Victor F. Tapson as VP of Medical Affairs
AQ
2021INARI MEDICAL : to Present at Upcoming Investor Conferences
AQ
2021INARI MEDICAL : Presentation August 2021
PU
2021INARI MEDICAL : Reports Second Quarter 2021 Financial Results (Form 8-K)
PU
2021INARI MEDICAL : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
2021INARI MEDICAL : Reports Second Quarter 2021 Financial Results 
AQ
2021INARI MEDICAL : to Present at the Canaccord Genuity 41st Annual Growth Conference
AQ
2021INARI MEDICAL : to Announce Second Quarter 2021 Financial Results
AQ
2021INARI MEDICAL : Appoints Outset Medical Executive Rebecca Chambers to Board of Directors (..
PU
2021INARI MEDICAL, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure,..
AQ
2021Inari Medical Appoints Outset Medical Executive Rebecca Chambers to Board of Directors
GL
2021INARI MEDICAL : Announces Late-Breaking CLOUT Registry Data Demonstrating Long-Term Benefi..
AQ
2021INARI MEDICAL, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021INARI MEDICAL, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021INARI MEDICAL : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
2021Inari Medical Reports First Quarter 2021 Financial Results
GL
2021INARI MEDICAL : Reports First Quarter 2021 Financial Results (Form 8-K)
PU
2021Inari Medical to Announce First Quarter 2021 Financial Results
GL
2021INARI MEDICAL : Announces Global Partnership with Aidoc to Advance the Timely Detection an..
AQ
2021INARI MEDICAL : Announces First Patient Enrolled in FLAME Study
AQ
2021INARI MEDICAL, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
AQ
2021INARI MEDICAL : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
2021Inari Medical Reports Fourth Quarter and Full Year 2020 Financial Results
GL
2021INARI MEDICAL : to Announce Fourth Quarter and Full Year 2020 Financial Results
AQ
2021Inari Medical to Present in Upcoming Investor Conferences
GL
2021INARI MEDICAL : Announces Presentation of Positive Chronic Clot Subanalysis Results from R..
AQ
2021Inari Medical Reports Preliminary Fourth Quarter 2020 Revenue
GL
2021INARI MEDICAL : FlowTriever System Receives FDA 510(k) Clearance for Treatment of Right At..
AQ
2021INARI MEDICAL : Appoints Venkat Tummala as VP of Medical Affairs and Justin Crockett as VP..
AQ
2020INARI MEDICAL, INC. : Other Events (form 8-K)
AQ
2020INARI MEDICAL : Announces Presentation of Positive 30-Day Follow-Up Results from First Pat..
AQ
2020Inari Medical Announces Presentation of Positive 30-Day Follow-Up Results from First Pa..
GL
2020INARI MEDICAL : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
2020INARI MEDICAL : Appoints Kevin Strange as VP of Strategy and Business Development and Ange..
AQ
2020INARI MEDICAL : Reports Third Quarter 2020 Financial Results
AQ
2020Inari Medical Reports Third Quarter 2020 Financial Results
GL
2020Inari Medical Appoints Kevin Strange as VP of Strategy and Business Development and Ang..
GL
2020INARI MEDICAL : to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Foru..
AQ
2020Inari Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics For..
GL
1  2Next
Upcoming event on INARI MEDICAL, INC.